Braidwell
Braidwell is a Stamford, Connecticut-based healthcare hedge fund founded in 2022 that manages approximately $3.1 billion across public and private markets for institutional LPs. Its 40-person team combines molecular biologists, biostatisticians, AI engineers, and portfolio managers to deploy flexible capital into AI-driven biopharmaceutical and healthcare technology companies.
- Company typePrivate
- Founded2022
- HeadquartersStamford, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Braidwell does
Braidwell is a privately held healthcare-focused investment firm, organized as Braidwell LP (Delaware), headquartered in Stamford, Connecticut. Founded in 2022 by Alex Karnal and Brian Kreiter, the firm provides flexible capital and partnership to healthcare companies across all stages of development and all parts of the capital structure, spanning both public and private markets. Its core product is the Braidwell Partners Fund, an AI-centered healthcare hedge fund that posted a 28% gross return in 2025 and managed approximately $3.1 billion in assets at year-end 2025, with $3.5 billion raised in cumulative capital since inception.
The firm is differentiated by an approximately 40-person team that combines molecular biologists, biostatisticians, AI engineers, and portfolio managers, enabling domain-specialized evaluation at the intersection of AI and biology. Braidwell's portfolio spans diagnostics (Guardant Health, GRAIL, Caris Life Sciences), medical devices (Alphatec Holdings, Impulse Dynamics), ophthalmology (Kodiak Sciences), proteomics (Alamar Biosciences), AI-native biotech (Lila Sciences, Proxima), and neuroprotection (Perceive Pharma), with capital deployed across venture rounds, private placements, structured debt, and public equities.
Braidwell generates revenue through management fees and performance allocations on its investment funds, distributed through direct institutional fundraising to qualified LPs including pension funds, endowments, foundations, and family offices. Go-to-market is sales-led and relationship-driven, reinforced by thought leadership via Bloomberg, Reuters, podcast appearances, and active LinkedIn presence from the co-founders. Specific fee economics are not publicly disclosed.
Braidwell firmographics
Firmographics- Name
- Braidwell
- Legal name
- Braidwell LP
- Website
- https://braidwell.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Braidwell is a Stamford, Connecticut-based healthcare hedge fund founded in 2022 that manages approximately $3.1 billion across public and private markets for institutional LPs. Its 40-person team combines molecular biologists, biostatisticians, AI engineers, and portfolio managers to deploy flexible capital into AI-driven biopharmaceutical and healthcare technology companies.
- Ownership category
- akta.pro rank
Braidwell industry classification
Industry- Product category
- Healthcare Investment Management
- NAICS
- Portfolio Management and Investment Advice (52394)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Multi-Sector / Generalist Growth Equity (FSANACAO)
Keywords
Where Braidwell is headquartered
LocationHeadquarters
- HQ city
- Stamford
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Braidwell business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Investment Management: Braidwell generates returns through managing healthcare-focused investment funds, providing flexible capital and thoughtful partnership to companies at all stages of development across public and private markets
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Braidwell product offering
Product offeringCore offering
Braidwell provides flexible capital and thoughtful partnership to healthcare companies at all stages of development, at all parts of the capital structure, across public and private markets. The firm operates its flagship Braidwell Partners Fund, a healthcare-focused hedge fund managed by an approximately 40-person team that combines molecular biologists, biostatisticians, AI engineers, and portfolio managers to invest in companies developing medicines, materials, and technologies that transform human health.
Product overview
Braidwell is a healthcare-focused investment firm operating as a single unified platform rather than a modular product suite. The core offering is the Braidwell Partners Fund, an AI-focused healthcare hedge fund that manages approximately $3.1 billion in assets. The firm provides flexible capital and partnership services to healthcare companies across all stages of development and all parts of the capital structure, spanning both public and private markets. The firm's approximately 40-person team combines expertise in molecular biology, biostatistics, AI engineering, and portfolio management to identify and build healthcare companies at the intersection of AI and biology.
Differentiator
Problem solved
Functional benefit
Products and services
- Braidwell Partners Fund Flagship healthcare hedge fund of Braidwell, focused on artificial intelligence investments in biopharmaceutical and healthcare technology companies. The fund posted a 28% gross return in 2025 and manages approximately $3.1 billion in assets under management. Available to qualified institutional limited partners.
- Flexible Capital and Partnership Services Braidwell's core service offering to healthcare companies: flexible capital and thoughtful partnership across all stages of development, at all parts of the capital structure, across public and private markets, including growth equity, non-dilutive debt, venture rounds, convertibles, and structured financings.
Quantifiable outcome
- 28% gross return in 2025
- +2 more outcomes
Companies that use Braidwell
Customer profileSegments1 record
Ideal customer profiles2 records
Braidwell technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Braidwell partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
Braidwell competitors and assessment
Company assessmentEmerging players
- ARCH Venture Partners: Venture-stage biotech investor with deep science orientation; comparable in research-driven approach but focused on earlier stages than Braidwell's flexible mandate.
- Kynam Capital: Healthcare-focused crossover manager with a public/private mandate similar to Braidwell's, though at an earlier stage of AUM growth.
Direct peers
- Cormorant Asset Management: Healthcare-focused investment manager with a public/private crossover strategy, often co-investing alongside Braidwell in private biotech rounds.
- Perceptive Advisors: Healthcare-focused investment firm with a crossover public/private strategy and deep life sciences research capabilities; one of the closest comparables to Braidwell's fund structure.
- OrbiMed Advisors: Healthcare-dedicated investment firm across private equity, public equity, and royalty/credit strategies—comparable in vertical specialization and capital-structure flexibility.
- RA Capital Management: Healthcare-focused crossover fund investing across public and private biotech with a research-driven, science-led approach—directly comparable to Braidwell's AI-augmented, healthcare-specialist model.
- Boxer Capital: Biotech-focused crossover fund making public and private investments in therapeutic companies; directly comparable in mandate and stage flexibility.
- Baker Bros. Advisors: Long-standing healthcare specialist managing both long-only and biotech-focused funds across public equities and venture; a benchmark crossover peer for Braidwell.
- D1 Capital Partners: Large crossover fund with significant healthcare exposure across public and private markets; competes with Braidwell for institutional LP capital and late-stage biotech deals.
Broad incumbents
- Deerfield Management: Healthcare-dedicated investment firm where Braidwell CIO Alex Karnal spent 16 years; broader and more established, with public market, private equity, and venture operations.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Braidwell social profiles
Digital presenceBraidwell financial estimates
Financial estimateRevenue estimate
Valuation estimate
Braidwell leadership team
Management profileNumber of profiles
Profiles2 records
Braidwell funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Braidwell M&A and investment
M&A and investmentM&A
Investments39 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Braidwell
What does Braidwell do?
Braidwell provides flexible capital and thoughtful partnership to healthcare companies at all stages of development, at all parts of the capital structure, across public and private markets. The firm operates its flagship Braidwell Partners Fund, a healthcare-focused hedge fund managed by an approximately 40-person team that combines molecular biologists, biostatisticians, AI engineers, and portfolio managers to invest in companies developing medicines, materials, and technologies that transform human health.
Is Braidwell a public or private company?
Braidwell is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Braidwell founded?
Braidwell was founded in 2022. It employs 11 to 50 people.
Where is Braidwell based?
Braidwell is headquartered in Stamford, United States, in the North America region.
How does Braidwell make money?
One revenue line is on record: investment Management.
Who are Braidwell's main competitors?
Emerging players on record are ARCH Venture Partners and Kynam Capital. Direct peers are Cormorant Asset Management, Perceptive Advisors, OrbiMed Advisors, RA Capital Management, Boxer Capital, Baker Bros. Advisors and D1 Capital Partners. Deerfield Management is listed as a broad incumbent.
Does Braidwell have an API?
No public API is recorded for Braidwell.
What industry is Braidwell in?
Braidwell's product category is Healthcare Investment Management. Its primary akta.pro industry code is FSANACAO, Multi-Sector / Generalist Growth Equity. Its NAICS code is 52394 and its SIC code is 6282.